Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jul 17;15(10):917–933. doi: 10.1038/cmi.2017.48

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Chinese Society of Immunology and The University of Science and Technology of China, All rights reserved 2017

PMC Copyright notice

Anti-proliferative function of HIV-1-treated B cells. Proliferation of autologous effector cells (EC) treated with CFSE and co-cultured with not-treated (NT) or treated B cells (ratio Breg:EC of 2:1) at day 3 post co-culture. As a control, EC were also cultured alone without B cells (EC non-activated and EC activated). Average±s.e.m. of the percentage of proliferative CD4+ and CD8+ T cells measured in anti-CD3/anti-CD28-stimulated EC in the presence of B cells. Values from five different donors are shown. *P<0.05 when comparing mock-treated condition versus treated conditions and ^# P<0.05 when comparing activated and non-activated EC cells.